Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography.
Blood-brain barrier transporters
FUS
Microbubbles
Radiotracers
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
10 08 2020
10 08 2020
Historique:
received:
20
02
2020
revised:
13
05
2020
accepted:
14
05
2020
pubmed:
20
5
2020
medline:
22
6
2021
entrez:
20
5
2020
Statut:
ppublish
Résumé
Focused ultrasound (FUS) is a minimally-invasive technology used for treatment of many diseases, including diseases related to the colon, uterus, prostate, and brain. Although it has been mainly used for ablative procedures, the ability of FUS to open the blood-brain barrier (BBB) presents a promising new application. However, the mechanism of BBB opening by FUS remains unclear. This review focuses on the use of FUS to open the BBB for enhancing drug delivery and investigating how Positron Emission Tomography (PET) provides insight into the underlying mechanism.
Identifiants
pubmed: 32428519
pii: S0168-3659(20)30297-2
doi: 10.1016/j.jconrel.2020.05.020
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
303-316Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.